Systematic Financial Management LP Medpace Holdings, Inc. Transaction History

Systematic Financial Management LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$92.95 - $130.61 $338,802 - $476,073	-3,645 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$68.08 - $95.68 $62,974 - $88,504	-925 Reduced 20.24%	3,645 $339,000
Q1 2020 May 12, 2020	SELL	$61.71 - $101.95 $221,847 - $366,510	-3,595 Reduced 44.03%	4,570 $335,000
Q4 2019 Feb 14, 2020	BUY	$70.08 - $84.64 $94,257 - $113,840	1,345 Added 19.72%	8,165 $686,000
Q3 2019 Nov 06, 2019	SELL	$62.38 - $85.89 $559,548 - $770,433	-8,970 Reduced 56.81%	6,820 $573,000
Q2 2019 Jul 26, 2019	SELL	$53.64 - $65.42 $373,066 - $454,996	-6,955 Reduced 30.58%	15,790 $1.03 Million
Q1 2019 May 03, 2019	BUY	$49.38 - $70.58 $30,615 - $43,759	620 Added 2.8%	22,745 $1.34 Million
Q4 2018 Feb 13, 2019	SELL	$46.97 - $63.98 $172,379 - $234,806	-3,670 Reduced 14.23%	22,125 $1.17 Million
Q3 2018 Nov 06, 2018	SELL	$43.25 - $63.74 $424,498 - $625,608	-9,815 Reduced 27.56%	25,795 $1.55 Million
Q2 2018 Aug 08, 2018	SELL	$34.03 - $45.46 $115,702 - $154,564	-3,400 Reduced 8.72%	35,610 $1.53 Million
Q1 2018 May 09, 2018	BUY	$32.03 - $39.05 $1.25 Million - $1.52 Million	39,010 New	39,010 $1.36 Million

654

25.6M

38.7K

79.5K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.4B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

Stay updated on Systematic Financial Management LP with notifications on news.